280 related articles for article (PubMed ID: 18022867)
21. Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.
Wang MH; Okazaki T; Kugathasan S; Cho JH; Isaacs KL; Lewis JD; Smoot DT; Valentine JF; Kader HA; Ford JG; Harris ML; Oliva-Hemker M; Cuffari C; Torbenson MS; Duerr RH; Silverberg MS; Rioux JD; Taylor KD; Nguyen GC; Wu Y; Datta LW; Hooker S; Dassopoulos T; Kittles RA; Kao LW; Brant SR
Inflamm Bowel Dis; 2012 Dec; 18(12):2277-87. PubMed ID: 22411504
[TBL] [Abstract][Full Text] [Related]
22. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
[TBL] [Abstract][Full Text] [Related]
23. Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn's Disease: On the Way to Personalized Medicine?
Hoffmann P; Lamerz D; Hill P; Kirchner M; Gauss A
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34198814
[TBL] [Abstract][Full Text] [Related]
24. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
[TBL] [Abstract][Full Text] [Related]
25. [Susceptibility genetic variants in Hungarian morbus Crohn and ulcerative colitis patients].
Magyari L; Melegh B
Orv Hetil; 2009 Jan; 150(2):81-8. PubMed ID: 19103559
[TBL] [Abstract][Full Text] [Related]
26. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans.
Yang SK; Park M; Lim J; Park SH; Ye BD; Lee I; Song K
Inflamm Bowel Dis; 2009 Sep; 15(9):1385-90. PubMed ID: 19334001
[TBL] [Abstract][Full Text] [Related]
27. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
[TBL] [Abstract][Full Text] [Related]
28. Contribution of rs11465788 in IL23R gene to Crohn's disease susceptibility and phenotype in Chinese population.
Bin C; Zhirong Z; Xiaoqin W; Minhu C; Mei L; Xiang G; Baili C; Pinjin H
J Genet; 2009 Aug; 88(2):191-6. PubMed ID: 19700857
[TBL] [Abstract][Full Text] [Related]
29. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population.
Newman WG; Zhang Q; Liu X; Amos CI; Siminovitch KA
J Clin Gastroenterol; 2009; 43(5):444-7. PubMed ID: 19276991
[TBL] [Abstract][Full Text] [Related]
30. ATG16L1 and IL23R variants and genetic susceptibility to crohn's disease: mode of inheritance based on meta-analysis of genetic association studies.
Grigoras CA; Ziakas PD; Jayamani E; Mylonakis E
Inflamm Bowel Dis; 2015 Apr; 21(4):768-76. PubMed ID: 25738374
[TBL] [Abstract][Full Text] [Related]
31. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G
Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
[TBL] [Abstract][Full Text] [Related]
32. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease.
Azzam N; Nounou H; Alharbi O; Aljebreen A; Shalaby M
Int J Mol Sci; 2012; 13(4):4268-4280. PubMed ID: 22605977
[TBL] [Abstract][Full Text] [Related]
33. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease.
Dubinsky MC; Wang D; Picornell Y; Wrobel I; Katzir L; Quiros A; Dutridge D; Wahbeh G; Silber G; Bahar R; Mengesha E; Targan SR; Taylor KD; Rotter JI;
Inflamm Bowel Dis; 2007 May; 13(5):511-5. PubMed ID: 17309073
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial peptide response to blood translocation of bacterial DNA in Crohn's disease is affected by NOD2/CARD15 genotype.
Gutiérrez A; Holler E; Zapater P; Sempere L; Jover R; Pérez-Mateo M; Schoelmerich J; Such J; Wiest R; Francés R
Inflamm Bowel Dis; 2011 Aug; 17(8):1641-50. PubMed ID: 21744420
[TBL] [Abstract][Full Text] [Related]
35. The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.
Jürgens M; Brand S; Laubender RP; Seiderer J; Glas J; Wetzke M; Wagner J; Pfennig S; Tillack C; Beigel F; Weidinger M; Schnitzler F; Kreis ME; Göke B; Lohse P; Herrmann K; Ochsenkühn T
J Gastroenterol; 2010 Jul; 45(7):721-31. PubMed ID: 20428899
[TBL] [Abstract][Full Text] [Related]
36. NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.
Cukovic-Cavka S; Vermeire S; Hrstic I; Claessens G; Kolacek S; Jakic-Razumovic J; Krznaric Z; Grubelic K; Radic D; Misak Z; Jadresin O; Rutgeerts P; Vucelic B
Eur J Gastroenterol Hepatol; 2006 Aug; 18(8):895-9. PubMed ID: 16825909
[TBL] [Abstract][Full Text] [Related]
37. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
38. Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.
Naser SA; Arce M; Khaja A; Fernandez M; Naser N; Elwasila S; Thanigachalam S
World J Gastroenterol; 2012 Feb; 18(5):412-24. PubMed ID: 22346247
[TBL] [Abstract][Full Text] [Related]
39. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort.
Wagner J; Sim WH; Ellis JA; Ong EK; Catto-Smith AG; Cameron DJ; Bishop RF; Kirkwood CD
PLoS One; 2010 Nov; 5(11):e15376. PubMed ID: 21079743
[TBL] [Abstract][Full Text] [Related]
40. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]